Analyzing Generics Market in Brazil 2017
Brazil has a booming pharmaceutical market. The pharmaceutical industry in Brazil is the sixth biggest in the world in terms of value. While generics does not have a leading market share in the industry as of yet, it is growing slowly. Prescription drugs account for nearly half of the market, while OTC drugs make up for 27% of the sector. Generics account for 23% as of present.
The generic industry in Brazil has been experiencing some decline in recent years, though it has managed to increase its market share. The market has seen fierce competition within domestic players and this has affected the overall value growth of the industry.
Aruvian Research presents Analyzing Generics Market in Brazil 2017 – a comprehensive coverage of the Brazilian generic drugs market. Beginning with a sectional description on the global generic industry, the report looks at an overview of the industry, an analysis of the market volume and value, industry segmentation and an industry forecast.
The Generics Industry in Brazil is analyzed through an industry overview which spans the data from 2012 till 2021. An analysis of the industry's value and volume data is included along with an industry segmentation by geography. Industry forecast of the industry is also included.
We also include a Porter’s Five Forces analysis of the Brazilian Generics Industry.
Analysis of the major industry players in the Brazilian generics market are analyzed through an analysis of their business segments, a financial analysis and a SWOT analysis. Players analyzed include O Ach? Laborat?rios Farmac?uticos SA, Sanofi, Eurofarma Laborat?rios Ltda and others. This concludes this comprehensive research report from Aruvian Research.
The generic industry in Brazil has been experiencing some decline in recent years, though it has managed to increase its market share. The market has seen fierce competition within domestic players and this has affected the overall value growth of the industry.
Aruvian Research presents Analyzing Generics Market in Brazil 2017 – a comprehensive coverage of the Brazilian generic drugs market. Beginning with a sectional description on the global generic industry, the report looks at an overview of the industry, an analysis of the market volume and value, industry segmentation and an industry forecast.
The Generics Industry in Brazil is analyzed through an industry overview which spans the data from 2012 till 2021. An analysis of the industry's value and volume data is included along with an industry segmentation by geography. Industry forecast of the industry is also included.
We also include a Porter’s Five Forces analysis of the Brazilian Generics Industry.
Analysis of the major industry players in the Brazilian generics market are analyzed through an analysis of their business segments, a financial analysis and a SWOT analysis. Players analyzed include O Ach? Laborat?rios Farmac?uticos SA, Sanofi, Eurofarma Laborat?rios Ltda and others. This concludes this comprehensive research report from Aruvian Research.
A. EXECUTIVE SUMMARY
B. ANALYZING THE GLOBAL GENERICS INDUSTRY
B.1 Industry Definition
B.2 Industry Overview
B.3 Industry Value & Volume Analysis
B.4 Industry Segmentation by Geography
B.5 Patent Expiries
B.6 Global Generic Industry Structure
B.7 Industry Forecast
C. GENERICS INDUSTRY IN BRAZIL
C.1 Industry Overview
C.2 Industry Value & Volume
C.3 Industry Segmentation by Geography
C.4 Industry Forecast
D. GENERICS INDUSTRY IN BRAZIL: PORTER’S FIVE FORCES STRATEGY ANALYSIS
D.1 Introduction
D.2 Bargaining Power of Buyers
D.3 Bargaining Power of Suppliers
D.4 Competitive Rivalry in the Industry
D.5 Threat of New Entrants
D.6 Threat of Substitutes
E. MAJOR INDUSTRY PLAYERS
E.1 Allergan Plc
E.1.1 Corporate Analysis
E.1.2 Financial Analysis
E.1.3 SWOT Analysis
E.2 Les Laboratoires Servier
E.2.1 Corporate Analysis
E.2.2 Financial Analysis
E.2.3 SWOT Analysis
E.3 Sanofi SA
E.3.1 Corporate Analysis
E.3.2 Financial Analysis
E.3.3 SWOT Analysis
E.4 EMS Sigma Pharma
E.5 Eurofarma Laborat?rios Ltda
E.6 O Ach? Laborat?rios Farmac?uticos SA
F. GLOSSARY OF TERMS
B. ANALYZING THE GLOBAL GENERICS INDUSTRY
B.1 Industry Definition
B.2 Industry Overview
B.3 Industry Value & Volume Analysis
B.4 Industry Segmentation by Geography
B.5 Patent Expiries
B.6 Global Generic Industry Structure
B.7 Industry Forecast
C. GENERICS INDUSTRY IN BRAZIL
C.1 Industry Overview
C.2 Industry Value & Volume
C.3 Industry Segmentation by Geography
C.4 Industry Forecast
D. GENERICS INDUSTRY IN BRAZIL: PORTER’S FIVE FORCES STRATEGY ANALYSIS
D.1 Introduction
D.2 Bargaining Power of Buyers
D.3 Bargaining Power of Suppliers
D.4 Competitive Rivalry in the Industry
D.5 Threat of New Entrants
D.6 Threat of Substitutes
E. MAJOR INDUSTRY PLAYERS
E.1 Allergan Plc
E.1.1 Corporate Analysis
E.1.2 Financial Analysis
E.1.3 SWOT Analysis
E.2 Les Laboratoires Servier
E.2.1 Corporate Analysis
E.2.2 Financial Analysis
E.2.3 SWOT Analysis
E.3 Sanofi SA
E.3.1 Corporate Analysis
E.3.2 Financial Analysis
E.3.3 SWOT Analysis
E.4 EMS Sigma Pharma
E.5 Eurofarma Laborat?rios Ltda
E.6 O Ach? Laborat?rios Farmac?uticos SA
F. GLOSSARY OF TERMS
LIST OF FIGURES
Figure 1: Historical Revenues of Leading Generic Companies (in USD Million), 2008-2009
Figure 2: Growth of the Global Generics Industry by Value (in USD Billion), 2012-2016
Figure 3: Generics Percentage of Total Pharmaceutical Volume & Market Volume of Global Generics Industry (%), 2012-2016
Figure 4: Global Generics Market Segmentation by Geography (%), 2016
Figure 5: Revenues of Top 10 Drugs that went off Patent between 2010-2014 (in USD Million)
Figure 6: Market Share of Leading Generic Companies Worldwide (%), 2016
Figure 7: Comparison of Revenues of Leading Generic Companies (in USD Million), 2013-2014
Figure 8: Global Generics Industry Forecast (in USD Billion), 2016-2021
Figure 9: Global Generics Industry Forecast by Volume (% of Pharma Volume), 2016-2021
Figure 10: Value of the Generics Market in Brazil (in USD Billion), 2012-2016
Figure 11: Volume Growth of the Generics Market in Brazil (%), 2012-2016
Figure 12: Share of Brazil in the Americas Generics Industry (%), 2016
Figure 13: Forecast of the Generics Market in Brazil (in USD Billion), 2016-2021
Figure 14: Volume Forecast of the Generics Market in Brazil (%), 2016-2021
Figure 15: Porter's Five Forces Strategy Analysis of the Generics Industry in Brazil
Figure 16: Bargaining Power of Buyers in the Brazilian Generics Industry
Figure 17: Bargaining Power of Suppliers in the Brazilian Generics Industry
Figure 18: Competitive Rivalry in the Brazilian Generics Industry
Figure 19: Threat of New Entrants to the Brazilian Generics Industry
Figure 20: Threat of Substitutes to the Brazilian Generics Industry
Figure 21: Revenues & Profitability of Allergan Plc (in USD Million), 2011-2015
Figure 22: Revenues & Profitability of Sanofi SA (in USD Million), 2011-2015
Figure 1: Historical Revenues of Leading Generic Companies (in USD Million), 2008-2009
Figure 2: Growth of the Global Generics Industry by Value (in USD Billion), 2012-2016
Figure 3: Generics Percentage of Total Pharmaceutical Volume & Market Volume of Global Generics Industry (%), 2012-2016
Figure 4: Global Generics Market Segmentation by Geography (%), 2016
Figure 5: Revenues of Top 10 Drugs that went off Patent between 2010-2014 (in USD Million)
Figure 6: Market Share of Leading Generic Companies Worldwide (%), 2016
Figure 7: Comparison of Revenues of Leading Generic Companies (in USD Million), 2013-2014
Figure 8: Global Generics Industry Forecast (in USD Billion), 2016-2021
Figure 9: Global Generics Industry Forecast by Volume (% of Pharma Volume), 2016-2021
Figure 10: Value of the Generics Market in Brazil (in USD Billion), 2012-2016
Figure 11: Volume Growth of the Generics Market in Brazil (%), 2012-2016
Figure 12: Share of Brazil in the Americas Generics Industry (%), 2016
Figure 13: Forecast of the Generics Market in Brazil (in USD Billion), 2016-2021
Figure 14: Volume Forecast of the Generics Market in Brazil (%), 2016-2021
Figure 15: Porter's Five Forces Strategy Analysis of the Generics Industry in Brazil
Figure 16: Bargaining Power of Buyers in the Brazilian Generics Industry
Figure 17: Bargaining Power of Suppliers in the Brazilian Generics Industry
Figure 18: Competitive Rivalry in the Brazilian Generics Industry
Figure 19: Threat of New Entrants to the Brazilian Generics Industry
Figure 20: Threat of Substitutes to the Brazilian Generics Industry
Figure 21: Revenues & Profitability of Allergan Plc (in USD Million), 2011-2015
Figure 22: Revenues & Profitability of Sanofi SA (in USD Million), 2011-2015
LIST OF TABLES
Table 1: Growth of the Global Generics Industry by Value (in USD Billion), 2012-2016
Table 2: Generics Percentage of Total Pharmaceutical Volume & Market Volume of Global Generics Industry (%), 2012-2016
Table 3: Global Generics Industry, Segmentation by Geography (in USD Billion), 2016
Table 4: Global Generics Industry Forecast (in USD Billion), 2016-2021
Table 5: Global Generics Industry Forecast by Volume & Percentage Growth (% of Pharma Volume), 2016-2021
Table 6: Value of the Generics Market in Brazil (in USD Billion), 2012-2016
Table 7: Volume Growth of the Generics Market in Brazil (%), 2012-2016
Table 8: Share of Brazil in the Americas Generics Industry (in USD Billion & %), 2016
Table 9: Forecast of the Generics Market in Brazil (in USD Billion), 2016-2021
Table 10: Volume Forecast of the Generics Market in Brazil (%), 2016-2021
Table 11: Key Financials of Allergan Plc (in USD Million), 2011-2015
Table 12: Key Financials of Sanofi SA (in USD Million), 2011-2015
Table 1: Growth of the Global Generics Industry by Value (in USD Billion), 2012-2016
Table 2: Generics Percentage of Total Pharmaceutical Volume & Market Volume of Global Generics Industry (%), 2012-2016
Table 3: Global Generics Industry, Segmentation by Geography (in USD Billion), 2016
Table 4: Global Generics Industry Forecast (in USD Billion), 2016-2021
Table 5: Global Generics Industry Forecast by Volume & Percentage Growth (% of Pharma Volume), 2016-2021
Table 6: Value of the Generics Market in Brazil (in USD Billion), 2012-2016
Table 7: Volume Growth of the Generics Market in Brazil (%), 2012-2016
Table 8: Share of Brazil in the Americas Generics Industry (in USD Billion & %), 2016
Table 9: Forecast of the Generics Market in Brazil (in USD Billion), 2016-2021
Table 10: Volume Forecast of the Generics Market in Brazil (%), 2016-2021
Table 11: Key Financials of Allergan Plc (in USD Million), 2011-2015
Table 12: Key Financials of Sanofi SA (in USD Million), 2011-2015
